Neuland Laboratories Ltd
Healthcare | Small Cap
Neuland Laboratories Ltd. demonstrates exceptional financial health, driven by outstanding profitability and remarkable growth. The company excels at converting revenue into profit and is expanding its sales and earnings at a very high rate. Its financial foundation is extremely solid, with very little reliance on debt, which significantly reduces long-term risks. Shareholders have benefited from strong growth in earnings and dividends. The main area of concern is operational efficiency; the company is slow in selling its inventory and collecting payments, and it does not generate as much sales from its assets as it could. While it has an adequate ability to meet its short-term bills, its cash generation from operations is a weaker point. The outlook is positive due to strong growth and profitability, but its future performance also depends on how well it manages its assets.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsHighly Overvalued
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio10.00
- Financial Ratio8.40
- Profitability Ratio10.00
- Efficiency Ratio2.67
- Coverage Ratio10.00
- Solvency Ratio10.00
- Liquidity Ratio6.28
- Peer Assessment
- Management AssessmentStrong
- Risk AssessmentBalanced
- 1 HourBullish
- 2 HoursBullish
- 4 HoursBullish
- 1 DayBullish
- 1 WeekBullish
- 1 MonthBullish
Neuland Laboratories Ltd. demonstrates exceptional financial health, driven by outstanding profitability and remarkable growth. The company excels at converting revenue into profit and is expanding its sales and earnings at a very high rate. Its financial foundation is extremely solid, with very little reliance on debt, which significantly reduces long-term risks. Shareholders have benefited from strong growth in earnings and dividends. The main area of concern is operational efficiency; the company is slow in selling its inventory and collecting payments, and it does not generate as much sales from its assets as it could. While it has an adequate ability to meet its short-term bills, its cash generation from operations is a weaker point. The outlook is positive due to strong growth and profitability, but its future performance also depends on how well it manages its assets.
Overall Valuation Score
P/E RATIO (TTM)
61.29
Industry Median
28.62
Small Cap Median
27.17
P/E RATIO
61.14
P/B RATIO
11.87
Industry Median
3.17
Small Cap Median
2.62
P/S RATIO
10.97
Industry Median
3.42
Small Cap Median
2.55
Others
PEG RATIO
1.58
EV/EBITDA RATIO
36.55
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹17345 as on Jun 21, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company is demonstrating excellent and robust growth across the board. It has achieved very high rates of expansion in its revenue, operating profits, and net income. This rapid growth is a clear indicator of strong market demand for its offerings and successful execution of its business strategy. While projections show some volatility with a dip in 2025, the overall trend points to a powerful growth trajectory, which is a key strength.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 1.49 | 25.24 | 30.9 | -5.26 | 36.97 |
| Operating Profit Growth Rate | -2.04 | 89.58 | 69.6 | -28.51 | 73.41 |
| Earnings Per Share (EPS) Growth | -20.86 | 156.23 | 83.52 | -13.32 | 39.94 |
| Asset Growth Rate | 4.38 | 14.24 | 16.01 | 18.93 | 34.4 |
| Net Income Growth Rate | -20.99 | 156.25 | 82.93 | -13.33 | 40 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
From a shareholder's perspective, the company's financial performance is strong. It delivers excellent earnings and cash flow per share, and its intrinsic book value is growing impressively. Dividend payments are also very healthy. The one area that stands out negatively is the significant and rising capital expenditure. While this represents a large use of cash, it is also a necessary investment to fuel the company's high-growth strategy, which is a positive for the long-term outlook.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 50 | 126.92 | 230.77 | 160 | 280 |
| Cash Earnings Per Share (Cash EPS) | 86.92 | 166.92 | 276.92 | 250.77 | 350.77 |
| Book Value Per Share | 646.92 | 764.62 | 986.92 | 1173.08 | 1442.31 |
| Dividend Per Share (DPS) | 4.97 | 10.2 | 14.03 | 12.16 | 34.05 |
| Capital Expenditures (CapEx) | 98 | 65 | 143 | 205 | 396 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company's profitability is excellent across all measures. It is highly effective at turning sales into profits, as shown by its strong margins. Furthermore, it generates outstanding returns on the capital invested by shareholders and lenders. This superior ability to generate profit and provide high returns on investment is a core strength of the business, indicating efficient management, strong pricing power, or a significant competitive advantage in its market.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 9.99 | 18.47 | 25.85 | 17.94 | 23.83 |
| Return on Capital Employed (ROCE) | 10 | 21 | 33 | 19 | 27 |
| Return on Equity (ROE) | 7.61 | 16.5 | 23.38 | 17.05 | 19.41 |
| Return on Assets (ROA) | 10.41 | 17.28 | 25.26 | 15.18 | 19.59 |
| Operating Margin | 15.14 | 22.92 | 29.7 | 22.41 | 28.37 |
| Net Margin | 6.73 | 13.77 | 19.24 | 17.6 | 17.99 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's operational efficiency is a significant area of weakness. It appears to be struggling to generate sufficient revenue from its assets, including its plant, equipment, and inventory. The process of converting inventory to sales and collecting cash from customers is slow. This indicates that a substantial amount of capital is tied up in operations, which can hinder financial flexibility and overall profitability, despite the company's strong performance in other areas.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 1.24 | 1.57 | 1.89 | 1.55 | 1.72 |
| Inventory Turnover Ratio | 3.34 | 3.57 | 3.68 | 3.29 | 3.44 |
| Receivables Turnover Ratio | 4.21 | 4 | 4.24 | 4.28 | 4.72 |
| Days Sales in Inventory Ratio | 109.28 | 102.24 | 99.18 | 110.94 | 106.1 |
| Receivable Days | 86.7 | 91.25 | 86.08 | 85.28 | 77.33 |
| Capital Turnover Ratio | 1 | 1.11 | 1.16 | 0.9 | 0.94 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company's capacity to meet its financial obligations is outstanding. It generates more than enough earnings to comfortably cover its interest payments, indicating a very low risk of default. Furthermore, its profits provide a very strong cushion for its dividend payments to shareholders. This combination of high coverage for both debt and dividends signals exceptional financial strength and reliability, which is highly favorable for both creditors and investors.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 6.86 | 17.62 | 29.64 | 44.25 | 21.38 |
| Equity Dividend Coverage Ratio | 10 | 12.5 | 16.67 | 16.67 | 8.33 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company's long-term financial stability is exceptional. It has a very low reliance on debt, with the vast majority of its operations funded by owner's equity. This conservative capital structure signifies extremely low financial risk and a very strong capacity to handle its long-term obligations. Creditors and investors can view the company as highly stable and creditworthy, with substantial capacity to take on new debt for future growth if needed.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.12 | 0.08 | 0.04 | 0.07 | 0.12 |
| Debt to Equity Ratio | 0.14 | 0.09 | 0.04 | 0.08 | 0.14 |
| Equity Ratio | 0.88 | 0.92 | 0.96 | 0.93 | 0.88 |
| Debt To Asset Ratio | 0.08 | 0.05 | 0.03 | 0.05 | 0.09 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's ability to meet its short-term financial obligations is adequate. It has a good capacity to cover immediate debts with its more liquid assets, which is a positive sign. However, its position is not overwhelmingly strong, as its cash reserves are average and the cash generated from core operations is on the weaker side. This indicates a manageable short-term financial standing but without a large safety cushion, suggesting a balance between holding cash and investing it back into the business.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 1.38 | 1.55 | 1.96 | 1.97 | 1.95 |
| Quick Ratio | 0.76 | 1 | 1.24 | 1.26 | 1.31 |
| Cash Ratio | 0.05 | 0.12 | 0.24 | 0.48 | 0.45 |
| Operating Cash Flow Ratio | 0.14 | 0.47 | 0.53 | 0.58 | 0.44 |
Current Ratios
Quick Ratios
Cash Ratios
Operating Cash Flow Ratios
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | J B Chemicals & Pharmaceuticals Ltd | 8.14 | 49.64 | Overvalued | 1107.00 | 41.98 | 709.00 |
| 2 | Gland Pharma Ltd | 7.91 | 35.27 | Overvalued | 1630.00 | 78.88 | 1027.00 |
| 3 | Neuland Laboratories Ltd | 7.84 | 61.14 | Highly Overvalued | 574.00 | 283.01 | 364.00 |
| 4 | Granules India Ltd | 7.73 | 32.77 | Highly Overvalued | 1185.00 | 16.17 | 595.00 |
| 5 | Ajanta Pharma Ltd | 7.72 | 36.27 | Neutral | 1395.00 | 75.78 | 1056.00 |
| 6 | Alembic Pharmaceuticals Ltd | 7.54 | 22.23 | Undervalued | 1118.00 | 32.58 | 671.00 |
| 7 | Syngene International Ltd | 7.44 | 56.08 | Overvalued | 918.00 | 7.55 | 317.00 |
| 8 | Emcure Pharmaceuticals Ltd | 7.40 | 36.42 | Neutral | 1865.00 | 38.66 | 941.00 |
| 9 | ERIS Lifesciences Ltd | 7.15 | 32.39 | Neutral | 1120.00 | 17.61 | 648.00 |
| 10 | Piramal Pharma Ltd | 5.83 | -64.86 | Neutral | 922.00 | 5.27 | -326.00 |
| 11 | Jubilant Pharmova Ltd | 5.71 | 38.62 | Neutral | 1260.00 | 1.25 | 398.00 |
| 12 | Natco Pharma Ltd | 5.69 | 11.22 | Neutral | 1436.00 | 71.55 | 1418.00 |
| 13 | Wockhardt Ltd | 5.07 | 153.40 | Neutral | 652.00 | 19.51 | 199.00 |
| 14 | Pfizer Ltd | 3.45 | 45.16 | Neutral | -82.00 | 157.92 | 300.00 |
| 15 | Procter & Gamble Health Ltd | 3.45 | 31.71 | Neutral | 457.00 | 196.94 | 327.00 |
| 16 | Sanofi India Ltd | 3.45 | 18.59 | Neutral | 491.00 | 134.52 | 413.00 |
Management demonstrates outstanding effectiveness, evidenced by explosive growth in sales and profits, and a dramatic improvement in margins (OPM up to 30%) and return metrics (ROCE at 33%). Prudent capital management is clear from the significant debt reduction (D/E ratio of 0.07) and strong interest coverage (33x). This financial turnaround has attracted significant FII investment. The primary weaknesses are high quarterly earnings volatility, a low dividend payout, and a declining promoter stake. However, the sheer scale of financial performance improvement and strengthening of the balance sheet are the dominant factors, pointing to highly effective management.
[{'Category': 'PROS', 'Metric': 'Strong Profit Growth', 'Value': '83% YoY', 'Assessment': 'Outstanding'}, {'Category': 'PROS', 'Metric': 'Improving Capital Efficiency', 'Value': 'ROCE 33%', 'Assessment': 'Excellent'}, {'Category': 'PROS', 'Metric': 'Excellent Debt Management', 'Value': 'D/E 0.07', 'Assessment': 'Very Strong'}, {'Category': 'PROS', 'Metric': 'Increasing Institutional Holding', 'Value': 'FIIs +6.29% YoY', 'Assessment': 'Strong'}, {'Category': 'CONS', 'Metric': 'Declining Promoter Holding', 'Value': '-3.4% YoY', 'Assessment': 'Weak'}, {'Category': 'CONS', 'Metric': 'Volatile Quarterly Performance', 'Value': 'Profit growth from +521% to -63%', 'Assessment': 'Volatile'}, {'Category': 'CONS', 'Metric': 'Low Dividend Payout', 'Value': '6%', 'Assessment': 'Weak'}]
Financial Performance & Growth
Neuland Labs has demonstrated exceptional financial performance, characterized by accelerating growth and margin expansion. Compounded sales growth has quickened from a 10-year average of 15% to a TTM rate of 31%. Profit growth is even more impressive, with a TTM growth of 83%, showcasing management's ability to scale profitability. A key strength is the significant improvement in operational efficiency. The Operating Profit Margin (OPM) has expanded dramatically from a low of 9% in 2019 to 30% in the latest fiscal year (Mar 2024), indicating superior cost control and a better product mix. The only notable concern is the high volatility in quarterly performance, where YOY sales and profit growth have fluctuated significantly. However, the overarching annual trend remains strongly positive. The majority of profits are derived from core operations, with other income forming a negligible part of the pre-tax profit, confirming the health of the primary business.
| Metric | 2018–2020 (Avg) | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Sales Growth (%) | 10.6% | 22.8% | 1.5% | 25.3% | 30.8% |
| Profit Growth (%) | -13.7% | 340.0% | -8.0% | 152.0% | 83.0% |
| OPM (%) | 10.7% | 16.0% | 15.0% | 23.0% | 30.0% |
Capital Efficiency & Returns
Management has achieved a remarkable turnaround in capital efficiency, transforming previously weak returns into industry-leading figures. The Return on Capital Employed (ROCE) is the most prominent indicator of this success, surging from a low of 4% in 2019 to an outstanding 33% in March 2024. This demonstrates highly effective allocation of capital towards profitable projects. Similarly, Return on Equity (ROE) has consistently improved, reaching 21% in the last year, indicating that shareholder funds are being used very productively to generate high returns. While the Cash Conversion Cycle remains elevated at 187 days, it has improved from a high of 216 days in 2022, indicating better working capital management. The combination of high and improving return ratios with more efficient asset utilization signals excellent management of the company's capital base.
| Metric | 2018–2020 (Avg) | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| ROCE (%) | 5.3% | 11.0% | 10.0% | 21.0% | 33.0% |
| ROE (%) | 11.3% | 11.0% | 7.0% | 18.0% | 21.0% |
| Cash Conversion Cycle | 187.7 | 164 | 216 | 193 | 187 |
Financial Health & Prudence
The company's financial health is exceptionally strong, reflecting a highly prudent and disciplined management approach. The most significant achievement has been the aggressive deleveraging of the balance sheet. Total borrowings have been systematically reduced from ₹241 Cr in March 2022 to just ₹95 Cr in March 2024. This has resulted in a near-zero Debt-to-Equity ratio of 0.07, placing the company in a very secure financial position with minimal leverage risk. This financial strength is further reinforced by a robust Interest Coverage Ratio, which has improved from an already healthy 21x to an exceptional 33x in the last year. This indicates that operating profits can cover interest expenses many times over, virtually eliminating any solvency concerns. The only minor weak point is a low Dividend Payout ratio of 6%, suggesting a focus on reinvesting earnings for growth over shareholder returns.
| Metric | 2018–2020 (Avg) | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Borrowings (₹ Cr) | 271.3 | 182 | 241 | 128 | 95 |
| Debt/Equity Ratio | 0.38 | 0.23 | 0.29 | 0.13 | 0.07 |
| Interest Coverage Ratio | 2.5 | 8.2 | 10.3 | 21.0 | 33.1 |
Shareholding & Ownership Structure
The ownership structure presents a mixed but evolving picture. A notable trend is the consistent decline in promoter holding, which has fallen from 36.14% to 32.74% in the last year. This steady reduction can be perceived as a weakness. However, this has been counterbalanced by a strong and growing interest from Foreign Institutional Investors (FIIs). FII holding has increased significantly, rising from 18.14% to 24.43% in the last year alone. This influx of institutional capital serves as a strong external validation of the company's performance and future prospects. Domestic Institutional Investors (DIIs) have maintained a relatively stable presence. The shift in ownership from promoters to institutions, particularly FIIs, suggests a transition in the shareholder base. While the promoter dilution is a concern, the strong institutional appetite is a significant positive.
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Promoter Holding (%) | 36.20% | 36.22% | 36.22% | 36.14% | 32.74% |
| FII Holding (%) | 26.97% | 17.21% | 17.21% | 18.14% | 24.43% |
| DII Holding (%) | 6.87% | 5.30% | 6.38% | 7.10% | 6.54% |
The overall risk profile is mixed. Financial risk is very low, supported by a robust balance sheet with minimal debt (D/E 0.07), strong cash flow generation, and excellent interest coverage. The company consistently converts profits into cash, indicating high-quality earnings with no apparent accounting red flags. However, a significant operational risk exists, highlighted by the extreme volatility in quarterly sales and profit growth. This unpredictability suggests a lumpy revenue model, possibly due to customer concentration or project-based business, which can impact earnings stability. Furthermore, the steady decline in promoter shareholding introduces a strategic risk related to long-term ownership alignment, even as rising FII interest provides a positive counterbalance.
Accounting Quality
The company demonstrates strong earnings quality, consistently converting a high percentage of net profit into cash from operating activities (CFO). In FY23, CFO was ₹237 Cr against a net profit of ₹164 Cr (144% conversion), and in FY24, CFO was ₹261 Cr against a net profit of ₹300 Cr (87% conversion). Furthermore, profit is driven by core business, with 'Other Income' contributing only a minor fraction (around 3% of PBT in FY24), which confirms that reported profits are not inflated by non-operational or one-off items. The alignment between reported profits and actual cash generation is a strong positive indicator of transparent and high-quality accounting practices.
Operational Risk (Earnings Volatility)
The company's financial results exhibit extreme volatility, indicating a high-risk operational profile. The quarterly year-on-year sales growth has seen wild swings, for example, from +64% in Jun 2023 to -26% in Sep 2024. This is mirrored in profitability, where YOY profit growth has fluctuated between a high of +521% and a projected low of -83%. This level of volatility suggests that the company's revenue streams are not stable or predictable on a quarterly basis. The likely cause is a dependence on large, irregular orders (lumpy revenue) or concentration in specific projects or customers. This operational characteristic poses a significant risk as it makes future earnings difficult to forecast and can lead to periods of underperformance.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1017295.10Bearish
- SMA 2017157.40Bullish
- SMA 5017049.52Bullish
- EMA 1017273.06Bullish
- EMA 2017189.28Bullish
- EMA 5017089.59Bullish
- DEMA 1017356.05Bearish
- DEMA 2017315.28Bearish
- DEMA 5017171.90Bullish
- TEMA 1017345.24Bearish
- TEMA 2017383.58Bearish
- TEMA 5017224.20Bullish
- MACD98.70Bullish
- ADX40.67Strong Trend
- IndicatorValueSignal
- RSI58.18Neutral
- CCI70.12Neutral
- ROC 90.09Bullish
- ROC 141.59Bullish
- ROC 253.45Bullish
- Stoch K75.10Neutral
- Stoch D77.32Neutral
- IndicatorValueSignal
- BB Upper17501.66Neutral
- BB Middle17157.40Neutral
- BB Lower16813.14Neutral
- ATR157.70High Volatility
- IndicatorValueSignal
- MFI70.10Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1017207.80Bullish
- SMA 2017049.20Bullish
- SMA 5017024.70Bullish
- EMA 1017206.94Bullish
- EMA 2017124.85Bullish
- EMA 5017037.02Bullish
- DEMA 1017321.13Bearish
- DEMA 2017221.12Bullish
- DEMA 5017170.82Bullish
- TEMA 1017366.27Bearish
- TEMA 2017293.04Bearish
- TEMA 5017104.60Bullish
- MACD83.69Bullish
- ADX27.38Strong Trend
- IndicatorValueSignal
- RSI59.58Neutral
- CCI90.26Neutral
- ROC 91.53Bullish
- ROC 143.28Bullish
- ROC 251.79Bullish
- Stoch K85.18Overbought
- Stoch D84.49Overbought
- IndicatorValueSignal
- BB Upper17474.83Neutral
- BB Middle17049.20Neutral
- BB Lower16623.57Neutral
- ATR215.84Low Volatility
- IndicatorValueSignal
- MFI71.65Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1017056.50Bullish
- SMA 2017061.40Bullish
- SMA 5016924.06Bullish
- EMA 1017126.59Bullish
- EMA 2017065.06Bullish
- EMA 5016790.47Bullish
- DEMA 1017212.99Bullish
- DEMA 2017158.68Bullish
- DEMA 5017488.51Bearish
- TEMA 1017271.25Bullish
- TEMA 2017153.86Bullish
- TEMA 50N/AN/A
- MACD76.34Bullish
- ADX21.83Weak Trend
- IndicatorValueSignal
- RSI57.14Neutral
- CCI104.34Overbought
- ROC 90.94Bullish
- ROC 142.20Bullish
- ROC 251.15Bullish
- Stoch K70.65Neutral
- Stoch D64.98Neutral
- IndicatorValueSignal
- BB Upper17399.59Neutral
- BB Middle17061.40Neutral
- BB Lower16723.21Neutral
- ATR334.04Low Volatility
- IndicatorValueSignal
- MFI66.68Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1017062.80Bullish
- SMA 2016989.00Bullish
- SMA 5016235.80Bullish
- SMA 10014558.28Bullish
- SMA 20015130.94Bullish
- EMA 1017072.64Bullish
- EMA 2016920.08Bullish
- EMA 5016161.58Bullish
- EMA 10015440.73Bullish
- EMA 20014820.93Bullish
- DEMA 1017179.92Bullish
- DEMA 2017307.51Bullish
- DEMA 5017273.18Bullish
- DEMA 10016315.51Bullish
- DEMA 20015920.33Bullish
- TEMA 1017187.48Bullish
- TEMA 2017118.86Bullish
- TEMA 5017761.80Bearish
- TEMA 10016943.95Bullish
- TEMA 20015811.17Bullish
- MACD267.02Bearish
- ADX23.82Weak Trend
- IndicatorValueSignal
- RSI60.50Neutral
- CCI139.20Overbought
- ROC 140.85Bullish
- ROC 253.99Bullish
- Stoch K64.13Neutral
- Stoch D50.35Neutral
- IndicatorValueSignal
- BB Upper17348.34Neutral
- BB Middle16989.00Neutral
- BB Lower16629.66Neutral
- ATR539.83Low Volatility
- IndicatorValueSignal
- MFI48.30Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 2014423.40Bullish
- SMA 5014767.94Bullish
- EMA 2015342.62Bullish
- EMA 5014514.52Bullish
- DEMA 2016170.71Bullish
- DEMA 5015821.18Bullish
- TEMA 2016818.17Bullish
- TEMA 5015505.38Bullish
- MACD741.54Bullish
- ADX28.95Strong Trend
- IndicatorValueSignal
- RSI59.31Neutral
- CCI100.06Overbought
- ROC 1431.95Bullish
- ROC 257.19Bullish
- Stoch K81.30Overbought
- Stoch D79.29Neutral
- IndicatorValueSignal
- BB Upper18298.24Neutral
- BB Middle14423.40Neutral
- BB Lower10548.56Neutral
- ATR1283.67Low Volatility
- IndicatorValueSignal
- MFI74.28Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 614228.17Bullish
- SMA 1214372.58Bullish
- SMA 2413289.31Bullish
- EMA 614824.45Bullish
- EMA 1214188.22Bullish
- EMA 2412593.49Bullish
- DEMA 615448.93Bullish
- DEMA 1215429.57Bullish
- DEMA 2415816.36Bullish
- TEMA 615776.66Bullish
- TEMA 1215117.77Bullish
- TEMA 2415964.90Bullish
- MACD3519.04Bullish
- ADX52.96Strong Trend
- IndicatorValueSignal
- RSI64.49Neutral
- CCI115.37Overbought
- ROC 25125.04Bullish
- ROC 501560.40Bullish
- Stoch K63.23Neutral
- Stoch D70.69Neutral
- IndicatorValueSignal
- BB Upper17708.83Neutral
- BB Middle13890.58Neutral
- BB Lower10072.33Neutral
- ATR2592.59High Volatility
- IndicatorValueSignal
- MFI66.71Neutral